Considering the beneficial effects offered by PKM2 overexpression on heart failure [29] and myocardial infarction [30], we asked whether SC may be alleviated by PKM2 through stabilizing PHB2 and supporting MQC in cardiomyocytes. The gene discussed is PHB2; the disease is heart failure.